{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-290709","form_type":"8-K","ticker":"BNTC","cik":"0001808898","company_name":"Benitec Biopharma Inc.","filed_at":"2023-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.571116+00:00","generated_at":"2026-06-07T16:21:08.412138+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Benitec Biopharma stockholders approve all four proposals at 2023 Annual Meeting","bullets":["Stockholders elected Edward Smith as director: 1,324,883 for, 54,894 withhold, 496,015 broker non-votes.","Ratification of independent auditor approved: 1,782,870 for, 57,064 against, 35,856 abstain.","Advisory vote on executive compensation approved: 1,327,852 for, 47,430 against, 4,493 abstain.","Amendment to 2020 Equity and Incentive Compensation Plan approved: 1,320,120 for, 56,877 against, 2,778 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-290709","json":"https://secwatch.observer/filing/0001193125-23-290709.json","markdown":"https://secwatch.observer/filing/0001193125-23-290709.md","text":"https://secwatch.observer/filing/0001193125-23-290709.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/d555443d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T16:21:08.412138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"248ee9ecc0ea727921640c5aa869b8037720489f","claim":"Benitec Biopharma Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-12-06 meeting.","evidence_excerpt":"Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm. The results were as follows: For Against Abstain 1,782,870 57,064 35,856","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-06"}],"fact_type":"shareholder_vote"},{"claim_id":"4ffef625692e356525116692a875a01ffaa60137","claim":"Benitec Biopharma Inc. shareholders approved Approval of Amendment to the 2020 Equity and Incentive Compensation Plan at the 2023-12-06 meeting.","evidence_excerpt":"Proposal 4 – Approval of Amendment to the 2020 Equity and Incentive Compensation Plan. The results were as follows: For Against Abstain Broker Non-Vote 1,320,120 56,877 2,778 496,015","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-06"}],"fact_type":"shareholder_vote"},{"claim_id":"62bbb7008e7f4ba06e4dff4884ec644357a5c6ee","claim":"Benitec Biopharma Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-12-06 meeting.","evidence_excerpt":"Proposal 3 – Advisory Vote on Executive Compensation. The results were as follows: For Against Abstain Broker Non-Vote 1,327,852 47,430 4,493 496,015","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-06"}],"fact_type":"shareholder_vote"},{"claim_id":"bd10db77c65fa8faa9d81366c4d4a0aade848ee3","claim":"Benitec Biopharma Inc. shareholders approved Election of Directors at the 2023-12-06 meeting.","evidence_excerpt":"Proposal 1 – Election of Directors . The results were as follows: Director Nominee For Withhold Broker Non-Votes Edward Smith 1,324,883 54,892 496,015","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312523290709/0001193125-23-290709-index.htm","confidence":0.98,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-06"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}